EF

Erik Fenster

TI Theravance Biopharma R&D Ip: 4 patents #5 of 40Top 15%
📍 San Bruno, CA: #6 of 91 inventorsTop 7%
🗺 California: #4,911 of 60,411 inventorsTop 9%
Overall (2018): #46,050 of 503,207Top 10%
4
Patents 2018

Issued Patents 2018

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDate
10123984 Neprilysin inhibitors Adam D. Hughes, Melissa Fleury, Roland Gendron, Edmund J. Moran 2018-11-13
10053417 Neprilysin inhibitors Melissa Fleury, Adam D. Hughes 2018-08-21
9872855 (2R,4R)-5-(5′-Chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid Melissa Fleury, Adam D. Hughes, Anne-Marie Beausoleil, Venkat R. Thalladi, Miroslav Rapta 2018-01-23
9868698 (2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid Adam D. Hughes, Melissa Fleury, Anne-Marie Beausoleil, Venkat R. Thalladi, Jerry Nzerem +1 more 2018-01-16